During this segment, Arthur Garson, Jr, MD, MPH, highlights the benefits of an evolving hospital discharge program, Grand-Aides.
Dr Garson discusses the role of a Grand-Aide, commonly a certified nurse aide, and his or her responsibilities to the patient and family members following discharge. He further explains that the Grand-Aide is not the decision maker for the patient, but rather a director of the patient’s care. Through telemedicine, the Grand-Aide records video and relays important information back and forth between a medical supervisor and the patient and family.
Dr Garson also discusses how the Grand-Aides program developed, and explains how the program has effectively improved patient care and reduced hospitalization costs, overall lengths of stay, and rates of readmission.
As this new model of care continues to evolve, Dr Garson explains, it will be important for the CMS to support payment for telemedicine and the Grand-Aides program.
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Data Show Leqvio's Effectiveness in Reducing LDL-C in Patients With ASCVD
April 11th 2024Results from the V-INITIATE trial showed a substantial 60% reduction in low-density lipoprotein cholesterol (LDL-C) from baseline to day 330 in the inclisiran first group compared with a mere 7% reduction in the usual care group.
Read More